20 Participants Needed

Home-Based Therapy for Cerebral Palsy

(HEIGHTEN Trial)

Recruiting at 1 trial location
AK
AH
Overseen ByAlicia Hilderley, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of the study is to assess implementation and effectiveness of a caregiver-delivered rehabilitation intervention for infants and toddlers with cerebral palsy.

Eligibility Criteria

This trial is for infants and toddlers aged three to 24 months with suspected or confirmed cerebral palsy, specifically hemiplegia or triplegia. They should have hand asymmetry identified by a clinician and be willing to engage in daily home-based therapy without other upper-limb treatments for 18 weeks.

Inclusion Criteria

My child is between 3 to 24 months old.
I am willing to do daily practice at home and attend weekly therapy for 18 weeks.
I have been diagnosed with cerebral palsy, affecting one side of my body or three limbs.
See 2 more

Exclusion Criteria

Issues with the nerves that control movement.
You were born with a difference in your upper limb.
I have an injury to the nerves in my shoulder.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Caregiver-delivered rehabilitation intervention for infants and toddlers with cerebral palsy

18 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

8 weeks

Treatment Details

Interventions

  • Home-based Therapy
Trial Overview The study tests the effectiveness of a caregiver-delivered rehabilitation program designed for young children with cerebral palsy at home. It aims to see how well families can implement this therapy and its impact on the child's condition.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Home-based TherapyExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Calgary

Lead Sponsor

Trials
827
Recruited
902,000+